Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 360 entries
View as:

Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT00055146 Org: User:
Start: 03/31/03 End: 05/31/06 Due: 05/31/07

A Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Participants With Moderate to Severe Obstructive Sleep Apnea, and in Adult and Elderly Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT04647383 Org: User:
Start: 01/06/21 End: 02/10/22 Due: 02/10/23

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10

Phase: N/A Priority: Normal
NCT ID: NCT00754013 Org: User:
Start: 09/30/08 End: 12/31/08 Due: 12/31/09

Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00096473 Org: User:
Start: 01/31/01 End: 09/30/05 Due: 09/30/06

A Pharmacokinetic Study to Assess the Influence of P-glycoprotein Inhibition and Simultaneous CYP3A4 and P-glycoprotein Induction on E7080 Pharmacokinetics Following Single Dose Oral Administration of 24 mg E7080 to Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02199392 Org: User:
Start: 11/30/11 End: 01/31/12 Due: 01/31/13

A Pharmacokinetic and Safety Study of E7080 in Subjects With Mild (10 mg), Moderate (10 mg), and Severe Hepatic Impairment (5 mg) and Normal Hepatic Function (10 mg)

Phase: N/A Priority: Normal
NCT ID: NCT02421042 Org: User:
Start: 06/30/11 End: 07/31/12 Due: 07/31/13

Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared to Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03440424 Org: User:
Start: 01/26/18 End: 04/23/18 Due: 04/23/19

Study of E7389 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00069264 Org: User:
Start: 09/30/03 End: 07/31/05 Due: 07/31/06

An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT01418677 Org: User:
Start: 10/31/11 End: 05/31/15 Due: 05/31/16

BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00603291 Org: User:
Start: 12/31/07 End: 10/31/10 Due: 10/31/11

Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure

Phase: N/A Priority: Normal
NCT ID: NCT01976104 Org: User:
Start: 11/30/13 End: 02/21/17 Due: 02/21/18

A Study to Demonstrate Bioequivalence Between 6 x 2 mg Tablets of Perampanel and a Single 12 mg Tablet of Perampanel in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01240187 Org: User:
Start: 06/30/10 End: 09/30/10 Due: 09/30/11

Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003

Phase: N/A Priority: Normal
NCT ID: NCT00625443 Org: User:
Start: 05/31/07 End: 10/31/09 Due: 10/31/10

A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS)

Phase: N/A Priority: Normal
NCT ID: NCT01830400 Org: User:
Start: 04/30/12 End: 06/30/14 Due: 06/30/15

Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN)

Phase: N/A Priority: Normal
NCT ID: NCT00592774 Org: User:
Start: 01/31/08 End: 03/31/09 Due: 03/31/10

Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00735397 Org: User:
Start: 10/31/08 End: 09/30/14 Due: 09/30/15

ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00659958 Org: User:
Start: 04/30/08 End: 09/30/09 Due: 09/30/10

Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia

Phase: N/A Priority: Normal
NCT ID: NCT01327859 Org: User:
Start: 03/31/03 End: 07/31/06 Due: 07/31/07

Evaluating the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor Polyneuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00927914 Org: User:
Start: 07/31/09 End: 02/28/13 Due: 02/28/14

A Study in Healthy Subjects to Evaluate Bioavailability of 4 Formulations of E5501

Phase: N/A Priority: Normal
NCT ID: NCT01549054 Org: User:
Start: 01/31/12 End: 08/31/12 Due: 08/31/13

A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01767311 Org: User:
Start: 12/20/12 End: 12/10/24 Due: 12/10/25

Crossover Study to Evaluate the Effect of Lemborexant Versus Placebo and Zolpidem on Postural Stability, Auditory Awakening Threshold, and Cognitive Performance in Healthy Subjects 55 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT03008447 Org: User:
Start: 11/21/16 End: 01/03/18 Due: 01/03/19

Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00327717 Org: User:
Start: 09/30/06 End: 05/31/08 Due: 05/31/09

A Study to Evaluate the Effect on 24-hour, Intragastric pH of RAB ER 50-mg Capsules Compared With Esomeprazole (Nexium) 40 mg Capsules and Rabeprazole (Aciphex) 20-mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01153659 Org: User:
Start: 07/31/10 End: 10/31/10 Due: 10/31/11

A Dose-Finding Study of E7389 in Combination With Carboplatin in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00268905 Org: User:
Start: 10/31/06 End: - Due: -